- Global Pharma News & Resources

Hyperpigmentation Treatment Market is anticipated to reach US$ 11.84 Billion by 2033, at a CAGR 9.5%

The hyperpigmentation treatment market size is poised for significant growth, with sales projected to increase at a robust CAGR of 9.5% from 2023 to 2033, resulting in a market size of US$ 11.84 billion by 2033. In 2023, the market is expected to reach US$ 4.78 billion, driven by factors such as the rising demand for outpatient and microsurgical procedures, continuous product innovations, and increased investments by key players.

Hyperpigmentation is a skin condition that leads to the appearance of dark patches due to excess melanin production. The market growth is fueled by the increasing prevalence of melasma and the growing awareness of hyperpigmentation treatments, which include chemical peels, cosmeceuticals, and laser treatments.

Get Sample PDF@

The hyperpigmentation treatment market is expected to benefit from the constant release of new products and significant investments in research and development by major players. In addition, the market is expected to expand due to the growing demand for outpatient and microsurgical procedures, increasing spending on cosmetic procedures, and the use of lasers in pigmentation diagnosis. The availability of laser therapy and phototherapy will also contribute to the market expansion.

The hyperpigmentation treatment market is expected to grow rapidly in both developed and developing nations due to advances in the medical sector. The rise in technological advancements in cosmeceuticals and the consequent increase in the use of pharmaceutical skincare products are expected to drive market growth. Additionally, increasing awareness of the disease and its treatment options, as well as the growing popularity of cosmeceuticals over traditional skincare products, are expected to drive market growth. The use of nanotechnology in cosmeceuticals is another factor that is expected to drive market growth during the forecast period.

Key Takeaways:

  • Poor reimbursement policies and the expensive nature of cosmetic procedures may deter the growth of the hyperpigmentation treatment market.
  • The US will emerge as the second-largest treatment market for hyperpigmentation in the upcoming years.
  • The hyperpigmentation treatment market in Asia Pacific will dominate the international market space owing to the rising awareness of the disease and its treatment options.
  • Based on treatment, the microdermabrasion segment will gain traction during the observation period with the crystal microdermabrasion device segment registering a CAGR of 9% in the US.
  • By application, the skin clinics category will observe greater demand and thereby contribute substantially to the overall market growth.

Avail Discount@

Competitive Landscape 

Vivier Pharma, La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer, Alvogen, Allergen, Obagi Medical Products, L’Oreal Paris, and SkinCeuticals, among others, are some of the prominent players in the hyperpigmentation treatment market profiled in the full version of the report.

Significant market players are concentrating on adopting progressive dermatological science and introducing innovative products. These enterprises also engage in various organic and inorganic business strategies to enhance their market position.

More Insights into Hyperpigmentation Treatment Market 

FMI offers the latest, unbiased, and detailed analysis of the global hyperpigmentation treatment market, providing historical data from 2018 to 2022 and forecast statistics for 2023 to 2033. For a comprehensive understanding of the global market potential, growth, and scope, the market is segmented on the basis of type, application, and region.

According to the reports, based on segmentation, the microdermabrasion treatment type will gain popularity over the coming years because of the various benefits associated with the treatment. In terms of application, the skin clinics segment will dominate the overall market.

Based on region, the North America and Asia Pacific hyperpigmentation treatment market will perform well during the forecast period. In 2021, the Asia Pacific market accounted for a 36% share. This regional market will continue to present strong growth in the upcoming years owing to growing awareness of the condition and its treatment option, a decline in cultural taboos, rising disposable income, and changes in lifestyle. The hyperpigmentation market in North America, too, will display notable growth during the projection period.

Request Report Customization@

Key Segments Profiled in the Hyperpigmentation Treatment Market Industry Survey

By Type:

  • Pharmacological Therapy
  • Laser Treatment
  • Chemical Peels and Bleach
  • Microdermabrasion
  • Skin Grafting or Plastic Surgery

By Application:

  • Skin Clinics
  • Drug and Cosmetic Stores
  • Hypermarkets and Supermarkets

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
United Arab Emirates
For Sales Enquiries:

Editor Details

Last Updated: 17-Mar-2023